A detailed history of Bruce G. Allen Investments, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 20 shares of UTHR stock, worth $7,949. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20
Previous 18 11.11%
Holding current value
$7,949
Previous $5.73 Million 24.99%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$311.04 - $363.55 $622 - $727
2 Added 11.11%
20 $7.17 Million
Q2 2024

Jul 12, 2024

BUY
$228.26 - $319.04 $4,108 - $5,742
18 New
18 $5.73 Million
Q4 2023

Jan 10, 2024

BUY
$214.88 - $256.94 $214 - $256
1 New
1 $220,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $18.1B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.